Shareholding disclosure

Varuma AG

Declared position

5.07%

Threshold

Crossed upwards

Timeline

Published

08.03.2007

Transaction

—

Voting rights breakdown

Voting rights acquired5.07%

Voting rights sold0%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

T4687D4476

Beneficial owner

Varuma AG

Declared address

Varuma AG, Basel

08.03.2007; Kotierungsprospekt

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Varuma AG

Basilea Pharmaceutica AG, Allschwil08.03.2007T4687D4476

Disclosure summary

Varuma AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil on the acquisition side, published by SIX Exchange Regulation on 08.03.2007, at 5.07% of voting rights. Notice category: Group of shareholders.

Disclosed position

5.07%

Voting rights acquired

Voting rights acquired5.07%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Varuma AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 08.03.2007.

Publication date08.03.2007

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerVaruma AG

Declared addressVaruma AG, Basel

CategoryGroup of shareholders

Voting rights acquired5.07%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDT4687D4476

Commercial register

CHE-101.305.572

Registered

Zefix record

Conditions

08.03.2007; Kotierungsprospekt

Source: SIX Exchange Regulation · Publication date: 08.03.2007

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open